Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

This study has been terminated.
(The EC withdrawn the approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene))
Sponsor:
Information provided by (Responsible Party):
Pier Luigi Zinzani, University of Bologna
ClinicalTrials.gov Identifier:
NCT00968331
First received: August 28, 2009
Last updated: August 24, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)